<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9832">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05689281</url>
  </required_header>
  <id_info>
    <org_study_id>10275</org_study_id>
    <nct_id>NCT05689281</nct_id>
  </id_info>
  <brief_title>Increasing PrEP With Trans Women in the Deep South</brief_title>
  <acronym>T'Cher</acronym>
  <official_title>T'Cher, Take Charge: Increasing PrEP Awareness, Uptake and Adherence Through Health Care Empowerment and Addressing Social Determinants of Health Among Racially Diverse Trans Women in the Deep South</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CrescentCare</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CrescentCare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this to address barriers and facilitators to PrEP uptake, and encourage adherence&#xD;
      among trans women via a single arm stepped wedge clinical trial. The main question is to&#xD;
      compare PrEP uptake and adherence outcomes among trans women in the T'Cher intervention to&#xD;
      the delayed study arm.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The intervention will also assess changes in health care empowerment and support for Social&#xD;
      Determinants of Health (SDoH) as mediating the effect of the intervention on PrEP uptake and&#xD;
      adherence among trans women.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 31, 2023</start_date>
  <completion_date type="Anticipated">July 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Participants will be recruited on a rolling basis for a randomized, unblinded, cross-over stepped wedge study design</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PrEP uptake</measure>
    <time_frame>24 months</time_frame>
    <description>The proportion of participants enrolled in the study who begin to take PrEP</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social determinant stressors</measure>
    <time_frame>24 months</time_frame>
    <description>The proportion of participants enrolled in the study who address social determinant stressors</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Health care empowerment</measure>
    <time_frame>24 months</time_frame>
    <description>The proportion of participants enrolled in the study who report improved healthcare empowerment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patterns and correlates of PrEP adherence</measure>
    <time_frame>24 months</time_frame>
    <description>Analysis of PrEP adherence among those who begin PrEP. Patterns and correlates of adherence will be measures using data from self report surveys and urine assays</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Hiv</condition>
  <arm_group>
    <arm_group_label>PrEP peer navigation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Culturally informed health care empowerment and PrEP peer navigation and support through social determinant of health stressors</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Peer PrEP Navigation</intervention_name>
    <description>Ecological momentary assessments to identify and address stressors related to social determinants of health (e.g., housing, substance use, mental health), and motivational interviewing to support participants' health care empowerment and progression along the PrEP continuum.</description>
    <arm_group_label>PrEP peer navigation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Provision of signed and dated informed consent form&#xD;
&#xD;
          -  Declaration of willingness to comply with all study procedures and availability during&#xD;
             the study&#xD;
&#xD;
          -  Age 18 years old or older&#xD;
&#xD;
          -  Male sex designated at birth&#xD;
&#xD;
          -  Identify as trans woman, woman or another gender identity not associated with being a&#xD;
             man&#xD;
&#xD;
          -  Desire to use or re-start PrEP&#xD;
&#xD;
          -  HIV uninfected&#xD;
&#xD;
          -  Speaks English or Spanish&#xD;
&#xD;
          -  Live in the New Orleans metropolitan statistical area (which includes 8 parishes)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Confirmed HIV infection by rapid algorithm testing and/or laboratory testing&#xD;
             (described above)&#xD;
&#xD;
          -  Prior or current participation in the active arm of an HIV vaccine trial with evidence&#xD;
             of vaccine-induced seropositivity&#xD;
&#xD;
          -  Concurrent or planned enrollment in a research study that provides PrEP&#xD;
&#xD;
          -  Unwilling to attend quarterly follow-up visits, which will include survey&#xD;
             participation&#xD;
&#xD;
          -  Has any other condition which, based on the opinion of the investigator, would&#xD;
             preclude provision of informed consent; make participation in the project unsafe;&#xD;
             complicate interpretation of outcome data; or otherwise interfere with achieving the&#xD;
             project objectives&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Trans woman</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Narquis Barak, MS</last_name>
    <phone>504.821.2601</phone>
    <phone_ext>1058</phone_ext>
    <email>narquis.barak@crescentcare.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Erin Meek, DrPH</last_name>
    <phone>628-217-6113</phone>
    <email>erin.wilson@sfdph.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NO/AIDS Task Force d.b.a. CrescentCare</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Narquis Barak, MA</last_name>
      <phone>504-821-2601</phone>
      <email>narquis.barak@crescentcare.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>January 6, 2023</study_first_submitted>
  <study_first_submitted_qc>January 17, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2023</study_first_posted>
  <last_update_submitted>March 3, 2023</last_update_submitted>
  <last_update_submitted_qc>March 3, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>CrescentCare</investigator_affiliation>
    <investigator_full_name>Narquis Barak</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

